<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0010">
 <label>10</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Hung</surname>
    <given-names>IF-N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lung</surname>
    <given-names>K-C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tso</surname>
    <given-names>EY-K</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial</article-title>. 
  <source>Lancet</source>
  <year>2020</year>;
  <volume>395</volume>:
  <fpage>1695</fpage>–
  <lpage>704</lpage>.
  <pub-id pub-id-type="pmid">32401715</pub-id>
 </mixed-citation>
</ref>
